Combined use of Pramipexol bio and Madopar ® in the treatment of parkinsonism

Male and female patients aged 18 years and older who gave written informed consent to participate in the study with Parkinson's disease, parkinsonism syndrome, were observed for 30 days. Patients of the main group received the drug "Pramipexol BIO" tablets of 0.25 mg. The drug was prescribed together with Madopar. Patients of the comparison group received Madopar for 30 days. The drug Pramipexole BIO 0.25 mg tablets in complex treatment with levodopa significantly expands the possibilities of anti-Parkinsonian therapy both in the early and late stages of PD and SP.